Literature DB >> 19637052

Cardiac autonomic neuropathy, estimated cardiovascular risk, and circadian blood pressure pattern in diabetes mellitus.

Jose Cabezas-Cerrato1, Ramon Carmelo Hermida, Jose Manuel Cabezas-Agricola, Diana Elva Ayala.   

Abstract

This study was designed to investigate potential factors involved in the disruption of the circadian blood pressure (BP) pattern in diabetes mellitus, as well as the relation between BP, cardiac autonomic neuropathy, and estimated cardiovascular risk. We studied 101 diabetic patients (58% with type 2 diabetes; 59% men), age 21-65 yrs, evaluated by 48 h BP monitoring. We performed three autonomic tests in a single session: deep breathing, Valsalva maneuver, and standing up from a seated position. Patients were classified according to the number of abnormal tests and their 10 yr risk of coronary heart disease or stroke. The prevalence of non-dipping 24 h patterning ranged from 47.6% in type 1 to 42.4% in type 2 diabetes. The awake/asleep ratio of systolic BP (SBP) was comparable between patients with or without abnormal autonomic tests. Pulse pressure (PP) was significantly higher in patients with > or =1 abnormal autonomic test (p < 0.001). Ambulatory SBP was significantly elevated in the group with higher risk of coronary heart disease (p < 0.001). Patients with higher stroke-risk had higher SBP but lower diastolic BP, and thus an elevated ambulatory PP by 9 mmHg, compared to those with lower risk (p < 0.001). Cardiac autonomic neuropathy is not the main causal-factor for the non-dipper BP pattern in diabetes mellitus. The most significant finding from this study is the high ambulatory PP found in patients with either cardiac autonomic dysfunction or high risk for coronary heart disease or stroke. After correcting for age, this elevated PP level emerged as the main cardiovascular risk factor in diabetes mellitus.

Entities:  

Mesh:

Year:  2009        PMID: 19637052     DOI: 10.1080/07420520903044448

Source DB:  PubMed          Journal:  Chronobiol Int        ISSN: 0742-0528            Impact factor:   2.877


  4 in total

1.  Effects of percutaneous coronary intervention on the ambulatory blood pressure of patients with hypertension and coronary heart disease.

Authors:  Jing Yang; Xuming Yang; Wei Liu; Tingting Cao
Journal:  Ir J Med Sci       Date:  2014-09-17       Impact factor: 1.568

2.  The analysis of blood pressure profiles and their severity in relation to diabetic cardiovascular autonomic neuropathy in the Chinese population: preliminary analysis.

Authors:  X Ge; H Chen; K Zhang; Z-H Tang
Journal:  J Endocrinol Invest       Date:  2016-03-03       Impact factor: 4.256

3.  Cardiovascular autonomic neuropathy and subclinical cardiovascular disease in normoalbuminuric type 1 diabetic patients.

Authors:  Ulrik Madvig Mogensen; Tonny Jensen; Lars Køber; Henning Kelbæk; Anne Sophie Mathiesen; Ulrik Dixen; Peter Rossing; Jannik Hilsted; Klaus Fuglsang Kofoed
Journal:  Diabetes       Date:  2012-04-12       Impact factor: 9.461

4.  Nocturnal antihypertensive treatment in patients with type 1 diabetes with autonomic neuropathy and non-dipping of blood pressure during night time: protocol for a randomised, placebo-controlled, double-blind, two-way crossover study.

Authors:  Henrik Hjortkær; Tonny Jensen; Klaus Kofoed; Ulrik Mogensen; Lars Køber; Karen Lisa Hilsted; Helle Corinth; Simone Theilade; Jannik Hilsted
Journal:  BMJ Open       Date:  2014-10-07       Impact factor: 2.692

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.